Jul 30, 2023, 18:18
Tumor microenvironment in recurrent HPV+ HNSCC patients treated with chemoradiation – Linda Chen
1/ Happy to share our study evaluating the tumor microenvironment in recurrent HPV+ HNSCC patients treated with chemoradiation Memorial Sloan Kettering Radiation Oncology.
We evaluated TIME composition in paired initial/recurrent tumors and report a novel depletion of TCF1+ T cells.
Source: Linda Chen/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14
Nov 14, 2024, 16:29
Nov 14, 2024, 16:27
Nov 14, 2024, 16:22
Nov 14, 2024, 16:22